Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-22-016069
Filing Date
2022-08-09
Accepted
2022-08-09 16:14:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 eftr_q2_2022_prosupp_9.htm 424B3 2201459
2 GRAPHIC img73299654_0.jpg GRAPHIC 33473
  Complete submission text file 0000950170-22-016069.txt   2248762
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-262339 | Film No.: 221148475
SIC: 2834 Pharmaceutical Preparations